Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 14: Perindopril - Endotheliale Dysfunktion Abb. 15: Perindopril - Endothliale Dysfunktion Abb. 16: Perindopril - Widerstandsarterien Aktuelles Bild - Abb. 17: Perindopril - Widerstandsarterien Abb. 18: Perindopril - Koronarreserve Abb. 19: Perindopril - Fibrinolyse Abb. 20: Perindopril - Antiatheriosklerotischer Effekt Zum letzten Bild
Abbildung 17: Perindopril - Widerstandsarterien
Perindopril normalises structure of coronary resistance arteries in patients with hypertensive heart disease. In the study where hypertensive patients with LVH and microvascular angina, were treated with perindopril 4 mg to 8 mg for 1 year, after the treatment period, perindopril had significantly decreased coronary resistance. Perindopril induced the regression of periarteriolar fibrosis of resistance vessels and of the interstitial collagen. This was accompanied by marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition with perindopril on coronary microcirculation in hypertensive heart disease, beyond BP control.
 
Perindopril - Widerstandsarterien
Vorheriges Bild Nächstes Bild   


Abbildung 17: Perindopril - Widerstandsarterien
Perindopril normalises structure of coronary resistance arteries in patients with hypertensive heart disease. In the study where hypertensive patients with LVH and microvascular angina, were treated with perindopril 4 mg to 8 mg for 1 year, after the treatment period, perindopril had significantly decreased coronary resistance. Perindopril induced the regression of periarteriolar fibrosis of resistance vessels and of the interstitial collagen. This was accompanied by marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition with perindopril on coronary microcirculation in hypertensive heart disease, beyond BP control.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung